Current Pharmaceutical Biotechnology
Title:Meet Our Editorial Board Member
Volume: 22 Issue: 5
Author(s): Antonella Fioravanti
Affiliation:
Export Options
About this article
Cite this article as:
Fioravanti Antonella , Meet Our Editorial Board Member, Current Pharmaceutical Biotechnology 2021; 22 (5) . https://dx.doi.org/10.2174/138920102205210326101516
DOI https://dx.doi.org/10.2174/138920102205210326101516 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Potential Serum Biomarkers in Multiple Sclerosis Identified by Proteomic Strategies
Current Medicinal Chemistry HIV-1 Infection and Chemokine Receptor Modulation
Current HIV Research Infectious Burden: A New Risk Factor and Treatment Target for Atherosclerosis
Infectious Disorders - Drug Targets <i>In Silico</i> Analysis, Synthesis, and Biological Evaluation of Triazole Derivatives as H1 Receptor Antagonist
Current Drug Discovery Technologies Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects
Current Medicinal Chemistry Circulating Osteoclast Precursors: A Mechanism and a Marker of Erosive Arthritis
Current Rheumatology Reviews Will it Ever Become Possible to Prevent Dopaminergic Neuronal Degeneration?
CNS & Neurological Disorders - Drug Targets Drugs of Abuse and Oxidative Stress in the Brain: From Animal Models to Human Evidence
Mini-Reviews in Organic Chemistry Regulation and Function of Rankl in Arterial Calcification
Current Pharmaceutical Design <i>In Silico</i> Identification of Novel APRIL Peptide Antagonists and Binding Insights by Molecular Modeling and Immunosorbent Assays
Protein & Peptide Letters DNA Binding Mode of Transition Metal Complexes, A Relationship to Tumor Cell Toxicity
Current Medicinal Chemistry Toxicities of Targeted Agents in Advanced Renal Cell Carcinoma
Current Clinical Pharmacology The Therapeutic Potential of Melatonin in Neurological Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Hydrogen Sulphide and Pain
Inflammation & Allergy - Drug Targets (Discontinued) An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients
Current Pharmaceutical Design LPS Up-Regulates Cystathionine γ -Lyase Gene Expression in Primary Human Macrophages via NF-κB/ERK Pathway
Inflammation & Allergy - Drug Targets (Discontinued) Endotoxin Neutralizing Peptides
Current Topics in Medicinal Chemistry Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer’s and Parkinson’s Diseases
Current Aging Science Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery
Current Topics in Medicinal Chemistry Recent Advances in Antiviral Agents: Antiviral Drug Discovery for Hepatitis Viruses
Current Pharmaceutical Design